155 related articles for article (PubMed ID: 7591703)
1. Does gonadotropin-releasing hormone administration affect serum growth hormone levels in poorly controlled insulin-dependent and non-insulin-dependent diabetes mellitus?
Gürlek A; Yordam N; Telatar F
Isr J Med Sci; 1995 Nov; 31(11):685-9. PubMed ID: 7591703
[TBL] [Abstract][Full Text] [Related]
2. TRH-induced growth hormone release in insulin-dependent diabetes mellitus.
Krassowski J; Jeske W; Zgliczyński S
Horm Metab Res; 1984 Dec; 16 Suppl 1():119-22. PubMed ID: 6442706
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults.
Kauppila M; Koskinen P; Irjala K; Remes K; Viikari J
Bone Marrow Transplant; 1998 Aug; 22(4):331-7. PubMed ID: 9722067
[TBL] [Abstract][Full Text] [Related]
4. Effect of growth hormone releasing hormone on growth hormone, prostaglandin E2 and insulin in non-insulin-dependent diabetic patients.
Koev D; Zacharieva S; Popova J; Andonova K
Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):137-40. PubMed ID: 8740245
[TBL] [Abstract][Full Text] [Related]
5. Suppression of growth hormone does not affect ongoing spermatogenesis in rats.
Awoniyi CA; Veeramachaneni DN; Roberts D; Tucker KE; Chandrashekar V; Schlaff WD
J Androl; 1999; 20(1):102-8. PubMed ID: 10100480
[TBL] [Abstract][Full Text] [Related]
6. [Non-specific pituitary responses in insulin-dependent diabetes mellitus in children and adolescents].
Iughetti L; Petraglia F; Facchinetti F; Genazzani AR; Cozzini A; Vanelli M; Bernasconi S
Presse Med; 1995 Dec 16-23; 24(39):1894-8. PubMed ID: 8745537
[TBL] [Abstract][Full Text] [Related]
7. Luteinizing hormone-releasing hormone and serum growth hormone in insulin-dependent diabetes.
Joffe BI; Distiller LA; Sagel J; Lawson M; Morley JE; Seftel HC
S Afr Med J; 1977 Jun; 51(26):979-80. PubMed ID: 329438
[TBL] [Abstract][Full Text] [Related]
8. Age-related decrease in hypothalamic gonadotropin-releasing hormone (GnRH) gene expression, but not pituitary responsiveness to GnRH, in the male Brown Norway rat.
Gruenewald DA; Naai MA; Marck BT; Matsumoto AM
J Androl; 2000; 21(1):72-84. PubMed ID: 10670522
[TBL] [Abstract][Full Text] [Related]
9. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
[TBL] [Abstract][Full Text] [Related]
10. Pituitary responsiveness to thyrotropin releasing hormone in insulin-dependent diabetes mellitus.
Morley JE; Klein C; Kalk WJ; Joffe BI; Saffer D; Distiller LA; Seftel HC
Horm Metab Res; 1978 May; 10(3):231-7. PubMed ID: 97197
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of the somatotropic axis in insulin dependent diabetes mellitus.
Mercado M; Baumann G
Arch Med Res; 1995; 26(2):101-9. PubMed ID: 7620273
[TBL] [Abstract][Full Text] [Related]
13. Central and peripheral administration of kisspeptin activates gonadotropin but not somatotropin secretion in prepubertal gilts.
Lents CA; Heidorn NL; Barb CR; Ford JJ
Reproduction; 2008 Jun; 135(6):879-87. PubMed ID: 18339687
[TBL] [Abstract][Full Text] [Related]
14. Pituitary function in patients with newly diagnosed untreated systemic lupus erythematosus.
Köller MD; Templ E; Riedl M; Clodi M; Wagner O; Smolen JS; Luger A
Ann Rheum Dis; 2004 Dec; 63(12):1677-80. PubMed ID: 15082470
[TBL] [Abstract][Full Text] [Related]
15. Non-specific response of serum growth hormone to thyrotropin-releasing hormone in diabetics.
Pan CY; Lu JM; Chang XM; Luo GC; Li H
Chin Med J (Engl); 1989 Jan; 102(1):41-4. PubMed ID: 2504551
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics with or without severe microvascular lesions.
Blickle JF; Schlienger JL; de Laharpe F; Stephan F
Diabete Metab; 1982 Sep; 8(3):197-201. PubMed ID: 6814964
[TBL] [Abstract][Full Text] [Related]
17. Pirenzepine decreases basal and stimulated GH secretion in patients with type 2 (non-insulin-dependent) diabetes mellitus.
Martina V; Pontiroli AE; Tagliabue M; Calderara A; Maccario M; Pacchioni M; Bertaina S; Bruno G; Pozza G; Camanni F
Horm Metab Res; 1994 Mar; 26(3):148-51. PubMed ID: 8005563
[TBL] [Abstract][Full Text] [Related]
18. Baseline follicle-stimulating hormone is a strong predictor for the outcome of the gonadotrophin-releasing hormone test in young men with unilateral medium- or high-grade varicocele.
Bach T; Pfeiffer D; Tauber R
BJU Int; 2006 Sep; 98(3):619-22. PubMed ID: 16925763
[TBL] [Abstract][Full Text] [Related]
19. Changes in serum glucose and serum growth hormone levels during pituitary surgery.
Maruyama K; Muneyuki M; Kojima T; Hashimoto H; Oi Y; Okuda M; Kurioka T; Fujita Y; Konishi K
Anesth Analg; 1987 Aug; 66(8):746-50. PubMed ID: 3605693
[TBL] [Abstract][Full Text] [Related]
20. The effect of exogenous growth hormone on insulin requirements during closed loop insulin delivery in insulin-dependent diabetes mellitus.
Bright GM; Melton RW; Rogol AD; Clarke WL
Horm Metab Res; 1984 Jun; 16(6):286-9. PubMed ID: 6389295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
